Oxtex Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oxtex Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10672
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxtex Ltd (Oxtex), formerly Oxtexs Ltd is a medical device company that offers novel self inflating tissue expansion and medical devices. The company’s products include implantable self-inflating tissue expanders that are suitable for specific needs of the clinician and the patient. It uses technology for tissue expansion to identify the improvement over existing self-inflating hydrogel expanders. Oxtex’s products find applications in reconstructive surgical procedures, dental and oral applications, veterinary surgery, restorative dentistry, and research and medical applications, among others. The company is developing specific devices that allow bespoke intra-operative shaping by the surgeon to secure an optimal fit for all patients. Oxtex is headquartered in Witney, the UK.

Oxtex Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxtex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxtex Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oxtex Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Oxtex Raises USD0.24 Million in Venture Financing 10
Oxtex Raises USD0.35 Million in Venture Financing 11
Partnerships 12
Oxtex Enters into Development Agreement with University of Malaya 12
Oxtex Ltd – Key Competitors 13
Oxtex Ltd – Key Employees 14
Oxtex Ltd – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Oxtex Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxtex Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxtex Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Oxtex Raises USD0.24 Million in Venture Financing 10
Oxtex Raises USD0.35 Million in Venture Financing 11
Oxtex Enters into Development Agreement with University of Malaya 12
Oxtex Ltd, Key Competitors 13
Oxtex Ltd, Key Employees 14

List of Figures
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oxtex Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxtex Ltd, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Oxtex Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grupo Mexico SAB de CV:戦略・SWOT・企業財務分析
    Grupo Mexico SAB de CV - Strategy, SWOT and Corporate Finance Report Summary Grupo Mexico SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Prana Biotechnology Ltd (PBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Prana Biotechnology Ltd (Prana Biotech) is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease and brain cancer, and other major age-related degenerative disorders. It is developing first-in-class therapies for the treatment of ne …
  • PT Tiphone Mobile Indonesia Tbk (TELE):企業の財務・戦略的SWOT分析
    PT Tiphone Mobile Indonesia Tbk (TELE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • International Finance Corporation:企業の戦略的SWOT分析
    International Finance Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Bunzl plc (BNZL):企業の財務・戦略的SWOT分析
    Bunzl plc (BNZL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CSA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary CSA Medical Inc (CSA Medical) is a medical device company that offers cryotherapy devices. The company provides spray cryotherapy medical device solutions to simplify procedures, improve patient outcomes, and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen s …
  • Naim Holdings Berhad:企業の戦略・SWOT・財務情報
    Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Naim Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PetroTal Corp (TAL):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroTal Corp (PetroTal), formerly known as Sterling Resources Ltd, is an oil and gas company that offers exploration, development and production of crude oil and natural gas properties. The company primarily operates in Bretana oil field in Peru, South America. PetroTal has operations in th …
  • Air Total International SA:企業の戦略的SWOT分析
    Air Total International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • UCB S.A.:企業の戦略・SWOT・財務分析
    UCB S.A. - Strategy, SWOT and Corporate Finance Report Summary UCB S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Amsted Industries Inc:企業の戦略・SWOT・財務分析
    Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Amsted Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Savannah Resources Plc:企業のM&A・事業提携・投資動向
    Savannah Resources Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Savannah Resources Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • MMRGlobal Inc (MMRF):企業の財務・戦略的SWOT分析
    MMRGlobal Inc (MMRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Swissport International Ltd.:企業の戦略・SWOT・財務情報
    Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swissport International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • W. L. Gore & Associates Inc:企業の戦略的SWOT分析
    W. L. Gore & Associates Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Schlumberger Ltd (SLB):石油・ガス:M&Aディール及び事業提携情報
    Summary Schlumberger Ltd (Schlumberger) is an oilfield services company that provides technology for reservoir characterization, drilling, production, and processing to the oil and gas industry. Schlumberger also supplies the industries with products and services, from exploration through production …
  • SECI Energia SpA:電力:M&Aディール及び事業提携情報
    Summary SECI Energia SpA (SECI Energia), a subsidiary of SECI SpA is an energy development service provider that operates in the construction, installation and management of renewable energy power plants. The company produces alternative energy through renewable sources. It provides renewable source …
  • IOI Corporation Berhad:企業の戦略・SWOT・財務分析
    IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary IOI Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Heineken NV:企業の戦略・SWOT・財務分析
    Heineken NV - Strategy, SWOT and Corporate Finance Report Summary Heineken NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Cristal Therapeutics BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Cristal Therapeutics BV (Cristal Therapeutics) is a pharmaceutical company that develops nano-medicines for the treatment of cancer and chronic inflammatory disorders. The company develops CriPec docetaxel, a lead product candidate for solid tumours. It also provides peptide-based products, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆